Skip to content

Medical emergency? What to do

BioSante says hot flash gel study is positive

3-RXPublished July 7, 20051 min read

Key points

  • Drug maker BioSante Pharmaceuticals Inc. on Wednesday said its experimental drug relieved hot flashes better than a placebo, and that it will soon file with U.S. regulators for approval.
  • Among 484 patients followed for 12 weeks on three doses of the investigational compound, patients experienced a drop in the frequency and severity of hot flashes by week 5, and as early as week 4 with higher doses.
  • There was no difference in trial discontinuation or drop outs among those on the treatment compared with those on a placebo, the company said.
  • Shares rose about 6 percent on the American Stock Exchange in opening trade.

Drug maker BioSante Pharmaceuticals Inc. on Wednesday said its experimental drug relieved hot flashes better than a placebo, and that it will soon file with U.S. regulators for approval.

Shares rose about 6 percent on the American Stock Exchange in opening trade.

Among 484 patients followed for 12 weeks on three doses of the investigational compound, patients experienced a drop in the frequency and severity of hot flashes by week 5, and as early as week 4 with higher doses.

Side effects of the gel, to be spread along arms and shoulders, included breast tenderness and nipple pain. No serious adverse events were detected.

There was no difference in trial discontinuation or drop outs among those on the treatment compared with those on a placebo, the company said.

Shares rose 23 cents to $4.06 on the American Stock Exchange in opening trade.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underDrug News

Keep reading

Cancer

Avastin Slows Resistant Ovarian Cancer

Progression of platinum-resistant ovarian cancer slowed by more than 50% in patients who received bevacizumab (Avastin) plus chemotherapy compared with nonplatinum chemotherapy alone, results of a randomized trial…

3 min read

Drug News

Prevnar trial results needed for CDC recommendation

Advisors to the U.S. Centers for Disease Control and Prevention on Wednesday will wait for results from a trial of Pfizer Inc's Prevnar 13 pneumonia vaccine before deciding whether to recommend its use in all adults…

1 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.